Virtual Reality Therapy on Dysphagia in Wallenberg Syndrome

Launched by COPKA SONPASHAN · Mar 18, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the use of Virtual Reality Therapy to help patients with dysphagia, which is difficulty swallowing, caused by Wallenberg Syndrome. The researchers want to find out if this new therapy can improve swallowing skills more effectively than standard treatment. Participants in the study will receive traditional dysphagia treatment along with Virtual Reality Therapy once a day for 14 days. The researchers will compare the results of these participants with a control group to understand how well the therapy works.

To be eligible for the trial, participants must be over 18 years old, right-handed, and have confirmed dysphagia through a special swallowing test. They should be stable and conscious, with no significant cognitive impairment. It's important that participants do not have other serious health issues that could interfere with the study. Those who join the trial can expect to take part in daily sessions aimed at improving their swallowing abilities using innovative technology. If you or a loved one are interested, this trial is currently not recruiting, but it will be open to patients who meet the criteria once it starts.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • age more than 18, and right-handed;
• • first onset, vital signs stable and conscious;
• • the dysphagia confirmed by videofluoroscopic swallowing study;
• • no cognitive impairment, the mini-mental state examination score: \>17 for those with an illiterate education, \>20 for those with an elementary education, and \>24 for those with a secondary education and above;
• • cranial integrity without craniotomy and/or craniectomy;
• • patient and/or his/her relative agrees and signs written informed consent.
• Exclusion Criteria:
• • combined ischemic foci at other sites;
• • presence of organic swallowing dysfunction or pre-existing dysphagia due to Parkinson's disease, dementia, and others;
• • severe cardiac, pulmonary, hepatic, and renal insufficiency and vital organ failure;
• • infected or broken skin on the head;
• • poorly controlled epilepsy;
• • poor patient compliance.